244 related articles for article (PubMed ID: 25040144)
1. Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery.
Prattes J; Hoenigl M; Rabensteiner J; Raggam RB; Prueller F; Zollner-Schwetz I; Valentin T; Hönigl K; Fruhwald S; Krause R
Mycoses; 2014 Nov; 57(11):679-86. PubMed ID: 25040144
[TBL] [Abstract][Full Text] [Related]
2. β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study.
Hanson KE; Pfeiffer CD; Lease ED; Balch AH; Zaas AK; Perfect JR; Alexander BD
PLoS One; 2012; 7(8):e42282. PubMed ID: 22879929
[TBL] [Abstract][Full Text] [Related]
3. Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
Cento V; Alteri C; Mancini V; Gatti M; Lepera V; Mazza E; Moioli MC; Merli M; Colombo J; Orcese CA; Bielli A; Torri S; Gasparini LE; Vismara C; De Gasperi A; Brioschi P; Puoti M; Cairoli R; Lombardi G; Perno CF
Mycoses; 2020 Dec; 63(12):1299-1310. PubMed ID: 32810888
[TBL] [Abstract][Full Text] [Related]
4. Potential clinical and economic outcomes of active beta-D-glucan surveillance with preemptive therapy for invasive candidiasis at intensive care units: a decision model analysis.
Pang YK; Ip M; You JHS
Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):187-194. PubMed ID: 27686799
[TBL] [Abstract][Full Text] [Related]
5. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
Bloos F; Held J; Schlattmann P; Brillinger N; Kurzai O; Cornely OA; Thomas-Rüddel D
Trials; 2018 Sep; 19(1):472. PubMed ID: 30180873
[TBL] [Abstract][Full Text] [Related]
6. (1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study.
Posteraro B; Tumbarello M; De Pascale G; Liberto E; Vallecoccia MS; De Carolis E; Di Gravio V; Trecarichi EM; Sanguinetti M; Antonelli M
J Antimicrob Chemother; 2016 Aug; 71(8):2262-9. PubMed ID: 27125554
[TBL] [Abstract][Full Text] [Related]
7. Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis.
Kritikos A; Poissy J; Croxatto A; Bochud PY; Pagani JL; Lamoth F
J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32238435
[TBL] [Abstract][Full Text] [Related]
8. Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients.
Presterl E; Parschalk B; Bauer E; Lassnigg A; Hajdu S; Graninger W
Int J Infect Dis; 2009 Nov; 13(6):707-12. PubMed ID: 19157947
[TBL] [Abstract][Full Text] [Related]
9. T2 Candida versus beta-D-glucan to facilitate antifungal discontinuation in the intensive care unit.
Gill CM; Kenney RM; Hencken L; Mlynarek ME; Alangaden GJ; Samuel LP; Davis SL
Diagn Microbiol Infect Dis; 2019 Oct; 95(2):162-165. PubMed ID: 31248660
[TBL] [Abstract][Full Text] [Related]
10. Can bacteraemia lead to false positive results in 1,3-beta-D-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections.
Metan G; Koc AN; Ağkuş Ç; Kaynar LG; Alp E; Eser B
Rev Iberoam Micol; 2012; 29(3):169-71. PubMed ID: 21907303
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation.
Reischies FM; Prattes J; Woelfler A; Eigl S; Hoenigl M
Transpl Infect Dis; 2016 Jun; 18(3):466-70. PubMed ID: 26992092
[TBL] [Abstract][Full Text] [Related]
12. β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.
Martín-Mazuelos E; Loza A; Castro C; Macías D; Zakariya I; Saavedra P; Ruiz-Santana S; Marín E; León C
Intensive Care Med; 2015 Aug; 41(8):1424-32. PubMed ID: 26134359
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
[TBL] [Abstract][Full Text] [Related]
14. Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.
Neofytos D; Railkar R; Mullane KM; Fredricks DN; Granwehr B; Marr KA; Almyroudis NG; Kontoyiannis DP; Maertens J; Fox R; Douglas C; Iannone R; Kauh E; Shire N
PLoS One; 2015; 10(6):e0129022. PubMed ID: 26107507
[TBL] [Abstract][Full Text] [Related]
15. Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.
Martínez-Jiménez MC; Muñoz P; Valerio M; Vena A; Guinea J; Bouza E
J Antimicrob Chemother; 2015 Nov; 70(11):3107-15. PubMed ID: 26311840
[TBL] [Abstract][Full Text] [Related]
16. Comparative sensitivity of 1,3 beta-D-glucan for common causes of candidaemia in South Africa.
Chibabhai V; Fadana V; Bosman N; Nana T
Mycoses; 2019 Nov; 62(11):1023-1028. PubMed ID: 31393662
[TBL] [Abstract][Full Text] [Related]
17. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
[TBL] [Abstract][Full Text] [Related]
18. Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan.
Nucci M; Nouér SA; Esteves P; Guimarães T; Breda G; de Miranda BG; Queiroz-Telles F; Colombo AL
J Antimicrob Chemother; 2016 Sep; 71(9):2628-33. PubMed ID: 27287231
[TBL] [Abstract][Full Text] [Related]
19. High level of β-(1,3)-d-glucan antigenaemia in cystic fibrosis in the absence of invasive fungal disease.
Rautemaa V; Green HD; Jones AM; Rautemaa-Richardson R
Diagn Microbiol Infect Dis; 2017 Aug; 88(4):316-321. PubMed ID: 28622948
[TBL] [Abstract][Full Text] [Related]
20. Blood product transfusions are associated with an increase in serum (1-3)-beta-d-glucan in infants during the initial hospitalization in neonatal intensive care unit (NICU).
Goudjil S; Chazal C; Moreau F; Leke A; Kongolo G; Chouaki T
J Matern Fetal Neonatal Med; 2017 Apr; 30(8):933-937. PubMed ID: 27188263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
